Tag Archives: Phil Nadeau

Analysts’ Top Healthcare Picks: La Jolla Pharma (LJPC), Odonate Therapeutics Llc (ODT)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on La Jolla Pharma (LJPC – Research Report) and Odonate Therapeutics Llc (ODT – Research Report) with bullish sentiments. La Jolla Pharma (LJPC)

Voyager Therapeutics Inc (VYGR) Receives a Buy from Cowen & Co.

In a report released yesterday, Phil Nadeau from Cowen & Co. maintained a Buy rating on Voyager Therapeutics Inc (VYGR – Research Report). The company’s shares closed yesterday at $13.87. According to TipRanks.com, Nadeau is a 5-star analyst with an

Cowen & Co. Remains a Buy on Atara Biotherapeutics (ATRA)

In a report released today, Phil Nadeau from Cowen & Co. maintained a Buy rating on Atara Biotherapeutics (ATRA – Research Report). The company’s shares opened today at $37.26. According to TipRanks.com, Nadeau is a 4-star analyst with an average

Galapagos NV (GLPG) Gets a Buy Rating from Cowen & Co.

Cowen & Co. analyst Phil Nadeau maintained a Buy rating on Galapagos NV (GLPG – Research Report) today. The company’s shares opened today at $98.18. According to TipRanks.com, Nadeau is a 4-star analyst with an average return of 4.8% and

Editas Medicine Inc (EDIT) Gets a Buy Rating from Cowen & Co.

Cowen & Co. analyst Phil Nadeau maintained a Buy rating on Editas Medicine Inc (EDIT – Research Report) today. The company’s shares opened today at $23.51. According to TipRanks.com, Nadeau is a 4-star analyst with an average return of 5.4%

Cowen & Co. Thinks Immunomedics’ Stock is Going to Recover

Cowen & Co. analyst Phil Nadeau maintained a Buy rating on Immunomedics (IMMU – Research Report) today and set a price target of $30. The company’s shares opened today at $11.87, close to its 52-week low of $11.55. According to